In the course of our screening program for new antitumor substances, a strain labeled A14106isolated from a soil sample collected in Shiroyama-cho, Mie Prefecture, Japan, was found to produce an active principle. This strain was classified as Streptomyces spheroides. The active principle was extracted from the mycelium of the strain with methanol and was purified by silica gel column chromatography. BE-14106 inhibited the growth of a vincristine-resistant P388 murine leukemia cell line as well as its parent sensitive cell line. BE-1 41 06 also displayed antimicrobial activity. This paper describes the taxonomy of the producing organism and the isolation, physico-chemical properties, biological activity and structure elucidation studies of BE-14106. The structure of BE-14106 is shown in Fig. 1 .
Materials and Methods Taxonomic Study
Characterization of the producing strain followed the method of the International Streptomyces Project (ISP)1*, and several other tests were also used. Morphological observations were madewith light and scanning electron microscopes. Cell wall analysis was performed by the method of Becker et al.2) and Yamaguchi3). Utilization of carbon sources was examined according to the method of Pridham and Gottlieb4*.
Fermentation
Spores of strain A14106 grown on agar slant medium were inoculated into several 500-ml conical flasks, each containing 100ml of a medium (pH 6.7) comprising glucose 0.1%, dextrin 2.0%, corn gluten meal 1.0%, fish meal 0.5%, yeast extract 0.1%, sodium chloride 0.1%, magnesium sulfate 0.05%, calcium chloride 0.05%, ferrous sulfate 0.0002%, cupric chloride 0.00004%, manganese chloride 0.00004%, cobalt chloride 0.00004%, zinc sulfate 0.00008%, sodium borate 0.00008%, ammonium molybdate 0.00024% and 3-(7V-morpholino)propanesulfonic acid 0.5% and were cultured on a rotary shaker (180rpm) at 28°C for 144 hours. Assay of Cytotoxic Activity
In the in vitro cytotoxic assay using the P388 tumor cell lines P388/S and P388/VCR, BE-14106 was first dissolved in dimethyl sulfoxide (DMSO). The solution was serially diluted with a cell culture medium containing 20% DMSO(20% DMSO-RPMI-1640 medium) with 2.5 x 104 tumor cells and the mixture was incubated under 5% CO2 at 37°C for 72 hours. The viable cells were then counted with a Coulter counter. The P388/S cell line is one of the mouse leukemia cell lines sensitive to antitumor agents, and the P388/VCRcell line is a subline of P388 leukemia that has acquired resistance to the antitumor agent vincristine5).
Instrumental Analyses
IR and UVspectra were recorded on a Hitachi 270-30 spectrometer and a Shimadzu UV-265FW spectrometer, respectively. Mass spectrometry was performed on a Jeol JMX-DX300spectrometer. *H and 13C NMRspectra were obtained using a Varian VXR300spectrometer at 300MHzand 75MHz, respectively. Chemical shifts were converted to values in ppmdownfield from TMSas an internal standard.
Results

Taxonomy of Strain A14106
The substrate mycelia of strain A14106 were well-developed and branched without fragmentation. The aerial mycelia branched monopodially and formed long spiral spore chains with more than 50 spores per chain. The spores, which were oblong in shape, were 0.4~0.5 x 0.7~0.9^m in size and had a smooth surface. Sporangia, sclerotia and zoospores were not observed. The cultural characteristics of strain A14106 are summarized in Table 1 . The aerial mass color was pale yellow to yellowish-white (yellow-color series). The reverse side of the growth was yellowish-brown to yellowish-white. Melanoid and other soluble pigments were not observed. The physiological properties and carbon source utilization of strain A14106 are summarizedin Tables 2 and 3 . Analysis of whole cell hydrolysates showed the presence of L,L-diaminopimelic acid. Accordingly, the cell wall of this strain is classified as type I.
Based on the above-mentioned taxonomic properties, strain A14106 is considered to belong to the genus Streptomyces. Accordingly, a comparison of this strain was made with published descriptions of Isolation Procedure The mycelium was obtained by filtration from the whole broth {ca. 6 liters) and washed with 2 liters of water. This mycelium was extracted with 2 liters of methanol, and the extract was concentrated under reduced pressure to yield 8.06g of a crude substance containing BE-14106. This crude substance was chromatographed on a column of silica gel (3 x 35 cm) and developed with chloroform -methanol (50 : 1). Fractions containing BE-14106 were collected and concentrated in vacuo. The resulting precipitate was triturated with 10 ml of methanol and filtered to afford BE-14106 (186 mg) as a colorless amorphous solid. Biological Activity In the cytotoxic assay, the concentration of BE-14106 required to inhibit growth of the P388/S and P388/VCRcell lines by 50% (IC50) was 1.65 and 1.89^m, respectively. The antimicrobial activity of BE-14106 is shown in Table 4 . With regard to the acute toxicity of BE-14106 in female ICR mice, no deaths were observed on the 5th day after lOOmg/kgwas intraperitoneally administered.
Structural Elucidation The molecular formula of BE-14106 (1) was established as C27H37O3Nfrom the results of the HRFAB-MS and NMRspectral analyses. In accordance with the UVspectrum, the *H NMRspectrum of 1 in DMSO-d6displayed fourteen olefinic protons in the range between 5.1 and 6.7ppm. Besides two olefinic methyl groups at 1.6 and 1.8 ppm, n-propyl, -CH2-CH(XH)-CH2-and -CH(OH)-CH(OH)- and 166.4 (s) ppm; one carbon overlapped in the solvent peak. Acetylation of 1 with acetic anhydride and pyridine afforded a diacetyl derivative of 1 (2, FAB-MS m/z 508 (M +'H)+), which exhibited improved solubility in chloroform and methanol. Analyses of the 1H-1H COSYspectra of 2 in CDC13and CD3OD,together with the decoupling experiments of 2, revealed three partial structures A, B and C as shown in Fig. 4 . The partial structure C was deduced from the decoupling experiments of 2 in CD3OD, because two protons overlapped at 6.19ppm in CDC13. The *H and 13C NMRdata for 2 in CDC13are shown in Table 5 . The assignments of the carbon VOL.45 NO.6 THE JOURNAL OF ANTIBIOTICS signals was accomplished by the^-^C COSYand long-range XH-13CCOSYspectral analyses. The connectivity of partial structures A and B was confirmed by the observation of^-^C long-range couplings between 13-H (6.17ppm) and C-27 (12.4ppm) and also between 15-H (5.98ppm) and C-13 (138.5ppm).
The carbonyl carbon at 167.2ppmwas assigned to be an amide carbon from the result of the^-^C long-range coupling of this carbon to the D2O-exchangeable proton at 5.00ppm and 2-H (5.76ppm). These observations show the connectivity of the partial structures of A and C. The remaining connectivity of the partial structures B and C was confirmed from the observation of^-^C long-range coupling of 7-H (5.19ppm) with C-5 (143.0ppm). The rraw-configuration of the C-6 and C-7 double bond was confirmed by the NOEobserved with 8-H on irradiation of 26-H. Also, the Jrans-configuration of C-14 and C-15 was confirmed by the NOE observed with 16-H on irradiation of 27-H.
Based on the above results, the structure of BE-14106 was determined to be the novel 20-membered macrocyclic lactam shown in Fig. 1 . Stubomycin (hitachimycin)7) has a similar structure to BE-14106, but stubomycin is a 19-membered lactam and has a phenyl group.
Diploid pairs of regulatory genes in adult cells are knownto suppress multiple structural genes capable of coding for transforming factors that can release the cell from its normal growth constraints8). The deletion or double mutation of these tumor suppressor genes and the mutation of cellular oncogenes predisposes the cells to cancer9). Thus, it is understood that cancer is a genetic disorder10). So, in addition to the screening of anti-oncogene product substances1^or substances that may be able to replace the function of suppressor gene products, the screening of cytotoxic substances and substances that indirectly suppress tumor growth12) must be performed until we are able to repair to functionally replace the damagedparts of the genes in tumor cells. In this context, biological target-oriented screening, cellular level screening and in vivo level screening must be performed in concert to find new lead substances for antitumor agents, along with further studies of currently available clinically useful drugs13~15). In the present study, we found a new macrocyclic lactam antibiotic that had cytotoxic activity against P388/S and P388/VCR cell lines. BE-14106 also showed antimicrobial activity comparable to that of stubomycin7), although its in vivo antitumor activity against murine experimental systems such as Ehrlich ascites tumor was not strong (data not shown). Chemical modification will be necessary to further evaluate this compound as an antitumor lead.
